6533b828fe1ef96bd128848f
RESEARCH PRODUCT
Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.
Olga PaciosLaura Fernández-garcíaInes BleriotLucía BlascoMónica González-bardancaMaría LópezFelipe Fernández-cuencaJesus Oteo-iglesiasÁLvaro PascualLuis Martínez-martínezPilar Domingo-calapGermán BouMaría TomásSpanish Society Of Infectious Diseases And Clinical Microbiology (Seimc). Study Group On Mechanisms Of Action And Resistance To Antimicrobials (Gemara)subject
0301 basic medicineImipenemKlebsiella pneumoniaemedicine.drug_classMitomycin030106 microbiologyAntibioticsResistanceDrug repurposingMicrobial Sensitivity TestsBacteriophage therapybeta-LactamasesMicrobiologyPersistence03 medical and health sciencesMechanisms of Resistancemedicinepolycyclic compoundsHumansPharmacology (medical)BacteriophagesPathogenhealth care economics and organizationsPharmacologybiologyMitomycin CBroth microdilutionbiochemical phenomena metabolism and nutritionbiology.organism_classificationAntimicrobialhumanitiesAnti-Bacterial AgentsKlebsiella InfectionsSynergyImipenemKlebsiella pneumoniae030104 developmental biologyInfectious DiseasesLytic cyclemedicine.drugdescription
Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).
year | journal | country | edition | language |
---|---|---|---|---|
2021-08-17 | Antimicrobial agents and chemotherapy |